These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9411827)

  • 1. [Means for increasing treatment efficacy in patients with ischemic heart disease].
    Chazov EI
    Ter Arkh; 1997; 69(9):5-10. PubMed ID: 9411827
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of a compound preparation pumpan on exercise tolerance and clinical course of ischemic heart disease].
    Krasnitskiĭ VB; Aronov DM; Zhidko NI
    Ter Arkh; 2003; 75(8):17-21. PubMed ID: 14520844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of the antioxidant coenzyme Q10 as a cytoprotection variant in ischemic heart disease].
    Syrkin AL; Kogan AKh; Drinitsina SV; Kuznetsov AB; Pechorina EA; Frenkel' EE; Kuleshova NN; Golovnia LD
    Klin Med (Mosk); 1998; 76(7):24-8. PubMed ID: 9742773
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analysis of pharmacotherapy and it's effectiveness in ischemic heart disease and arterial hypertension, conducted by doctors in specialist and regional outpatient clinics].
    Guzecka-Ruszczyńska E; Czarnecki A
    Wiad Lek; 1994 May; 47(9-10):352-7. PubMed ID: 7817593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The work experience of a polyclinic functional diagnosis office in improving the care for patients with arterial hypertension and ischemic heart disease].
    Sivkova SK; Larionov PV
    Ter Arkh; 1993; 65(1):49-52. PubMed ID: 8036573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in ischaemic heart disease].
    Alegria E; Velasco A; Azcárate P
    Rev Med Univ Navarra; 2005; 49(3):16-30. PubMed ID: 16400973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The possibilities for real improvement in the prognosis and quality of life of patients with ischemic heart disease].
    Ter Arkh; 1996; 68(9):10-8. PubMed ID: 9005603
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperlipoproteinemic states and ischemic heart disease.
    Prusinski L; Eisold JF
    Dent Clin North Am; 1996 Jul; 40(3):563-84. PubMed ID: 8829046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The programmed therapy of rhythm and conduction disorders in ischemic heart disease].
    Ardashev VN; Steklov VI
    Voen Med Zh; 1997 Jul; 318(7):32-8. PubMed ID: 9334034
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug correction of myocardial ischemia in patients with chronic obstructive bronchitis].
    Chicherina EN; Malykh SV
    Probl Tuberk Bolezn Legk; 2003; (11):19-22. PubMed ID: 14689792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficiency and safety of a long-lasting form of diltiazem in the treatment of hypertensive patients with ischemic heart disease].
    Svetyĭ LI; Pavlova LI; Mazerkina IA
    Klin Med (Mosk); 2002; 80(8):58-61. PubMed ID: 12360623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gopten (trandolapril) in the treatment of chronic heart failure in patients with ischemic heart disease].
    Kakhnovskiĭ IM; Fomina IG; Ostroumov EL; Lepeshkov VM; Gaĭdamakina NE; Kaveshnikova OV; Markova ZS; Lugovaia EL
    Ter Arkh; 1998; 70(8):29-33. PubMed ID: 9770740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The therapeutic prospects of ischemic cardiopathy].
    Rossi F; Matera MG; Filippelli A; Giasi M; Fici F
    Clin Ter; 1994 Apr; 144(4):333-53. PubMed ID: 8205757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of ischemic heart disease: old traditions and new trends].
    Belenkov IuN
    Ter Arkh; 2005; 77(9):5-8. PubMed ID: 16281480
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advances in study on the nature products of anti-myocardial ischemia].
    Zhang C; Xu D; Mei X; Xu S
    Zhong Yao Cai; 2003 Apr; 26(4):288-94. PubMed ID: 14528698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indices of lipid peroxidation and atherogenic blood lipoproteins in patients with coronary heart disease receiving antioxidants in addition to basic therapy].
    Reĭzin AB; Tel'nykh IuV
    Klin Med (Mosk); 2005; 83(11):63-4. PubMed ID: 16404943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances].
    Petelina TI; Gapon LI; Bakhmatova IuA; Zhevagina IA
    Ter Arkh; 2005; 77(8):19-23. PubMed ID: 16206600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chronotherapeutic approach to the management of high-risk patients with hypertension/ischemic heart disease: introduction.
    Black HR
    Am J Hypertens; 1999 Feb; 12(2 Pt 2):33S-34S. PubMed ID: 10090292
    [No Abstract]   [Full Text] [Related]  

  • 19. [The anti-arrhythmia action of tiracizine in patients with ischemic heart disease and decreased myocardial contractile function].
    Mishin IuI; Kliachkina IL; Ivashkin VT; Min'kova TI; Bannikova SD
    Voen Med Zh; 1997 Jun; 318(6):44-7. PubMed ID: 9412062
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocardial metabolism: pharmacological manipulation in myocardial ischaemia.
    Mitra B; Panja M
    J Assoc Physicians India; 2005 Jun; 53():552-60. PubMed ID: 16121812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.